Innovent Biologics Inc (6IB) — Tangible Net Worth Ratio
Innovent Biologics Inc (6IB) has a Tangible Net Worth Ratio of 90.3% as of December 2025. This metric is calculated by deducting intangible assets (€1.88 Billion) from net assets (€19.36 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Innovent Biologics Inc (6IB) equity growth momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Innovent Biologics Inc Tangible Net Worth Ratio (2018–2025)
This chart shows how Innovent Biologics Inc's Tangible Net Worth Ratio has changed across 8 annual periods from 2018 to 2025. As of December 2025, the ratio stands at 90.3%, reflecting net assets of €19.36 Billion with intangible assets of €1.88 Billion EUR. For live market cap and overall valuation, see Innovent Biologics Inc (6IB) market capitalisation.
Annual Tangible Net Worth Ratio for Innovent Biologics Inc (2018–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Innovent Biologics Inc from 2018 to 2025, covering 8 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore 6IB capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 90.3% | €19.36 Billion | €1.88 Billion | €37.35 Billion | ▲ +2.8 pp |
| 2024 | 87.5% | €13.12 Billion | €1.64 Billion | €21.60 Billion | ▼ -2.3 pp |
| 2023 | 89.9% | €12.53 Billion | €1.27 Billion | €20.63 Billion | ▲ +1.0 pp |
| 2022 | 88.8% | €10.73 Billion | €1.20 Billion | €17.59 Billion | ▼ -3.7 pp |
| 2021 | 92.5% | €10.33 Billion | €772.19 Million | €16.24 Billion | ▼ -7.1 pp |
| 2020 | 99.6% | €8.78 Billion | €32.62 Million | €11.83 Billion | ▼ -0.4 pp |
| 2019 | 100.0% | €4.76 Billion | €0.00 | €7.23 Billion | ▲ +1.3 pp |
| 2018 | 98.7% | €4.19 Billion | €52.84 Million | €6.11 Billion | — |